Newsroom

Sorted by: Latest

-

Anaergia Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call

BURLINGTON, Ontario--(BUSINESS WIRE)--Anaergia (TSX: ANRG, OTCQX: ANRGF) reports Q3 2026 results Nov. 11 after market close; CEO, CFO and COO host call and webcast Nov. 12 at 9:30 a.m. EST...
-

ThetaRay Named World’s Best Software Provider for AML and Sanctions Screening in the 2026 Euromoney Transaction Banking Awards

LONDON--(BUSINESS WIRE)--ThetaRay named the world's best software provider for AML and sanctions screening by Euromoney Transaction Banking Awards 2026....
-

Le Sénégal entre dans l’histoire : le président Faye inaugure les premiers Jeux olympiques de la jeunesse organisés sur le sol africain

DAKAR, SÉNÉGAL--(BUSINESS WIRE)--Le Sénégal est entré dans l’histoire samedi lorsque le président Bassirou Diomaye Faye a officiellement déclaré ouverts les Jeux olympiques de la jeunesse de Dakar 2026, marquant ainsi la première organisation de cet événement sportif international destiné aux jeunes sur le continent africain. La cérémonie d’ouverture s’est déroulée le 31 octobre au stade Abdoulaye Wade de Diamniadio, d’une capacité de 50 000 spectateurs. Elle a réuni 1 115 artistes et figurants...
-

AppLovin Corporation (APP) Investors: November 16, 2026, Deadline in Securities Fraud Class Action Lawsuit - Kessler Topaz Meltzer & Check, LLP

RADNOR, Pa.--(BUSINESS WIRE)--Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud class action lawsuit has been filed against AppLovin Corporation (AppLovin) (NASDAQ: APP) on behalf of those who purchased or acquired AppLovin securities between February 12, 2026 and August 5, 2026, inclusive. The lawsuit is filed in the United States District Court for the Northern District of California and is...
-

HSBC Bank Plc UK Regulatory Announcement: Early Repurchase(s)

LONDON--(BUSINESS WIRE)--  ISIN GB00BTDGRJ57 Issuer Name HSBC BANK PLC Paying Agent HSBC Bank Plc Redemption Type Repurchase Currency USD O/S Balance 8,771,900.00 New Balance 0.00 Value Date 04-Nov-26  ...
-

شركة Rimini Street فازت باتفاقية إطارية لتقديم خدمات الصيانة من جهة خارجية لصالح CANUT

لاس فيجاس--(BUSINESS WIRE)--أعلنت اليوم شركة Rimini Street, Inc.‎ (بورصة ناسداك: RMNI)، المتخصصة في دعم البرمجيات وأنظمة ERP المدعومة بالذكاء الاصطناعي الوكيلي™، والمزوّد الرائد لخدمات الدعم الخارجي لبرمجيات Oracle وSAP وVMware، عن اختيارها جهةً فائزةً بحصص خدمات الدعم المقدمة من جهات خارجية (TMA) من جانب CANUT، مركز المشتريات العامة الفرنسي المتخصص في التكنولوجيا الرقمية والاتصالات.يتناول هذا البيان الصحفي الوسائط المتعددة. يمكنك الاطلاع على البيان كاملاً هنا: https://www.businesswire.com/news/...
-

Deadline Alert: O-I Glass, Inc. Shareholders Have Until December 28, 2026 to Seek Lead Plaintiff Appointment in Securities Fraud Lawsuit, The Law Offices of Frank R. Cruz Notes

LOS ANGELES--(BUSINESS WIRE)--The deadline for O-I Glass, Inc. ("O-I Glass" or the "Company") (NYSE: OI) investors to seek appointment as lead plaintiff in a securities class action lawsuit is December 28, 2026. The lawsuit was filed on behalf of investors who purchased or otherwise acquired O-I Glass, Inc. securities from March 14, 2025 to July 28, 2026, inclusive. The Law Offices of Frank R. Cruz today reminded investors of the deadline in the case, Bryan v. O-I Glass, Inc. et al., filed on Oc...
-

HSBC Bank Plc UK Regulatory Announcement: Early Repurchase(s)

LONDON--(BUSINESS WIRE)--  ISIN GB00BTDGSD60 Issuer Name HSBC BANK PLC Paying Agent HSBC Bank Plc Redemption Type Repurchase Currency USD O/S Balance 37,037,037.00 New Balance 0.00 Value Date 04-Nov-26  ...
-

Trained Therapeutix Discovery 任命 Andrew Glass 为首席执行官

达拉斯及荷兰奥斯--(BUSINESS WIRE)--(美国商业资讯)-- 免疫治疗领域的先驱企业 Trained Therapeutix Discovery(简称“TTxD”)宣布,任命 Andrew Glass 为首席执行官,即日起生效。公司由 Jean Boulle Group 和 Heritage Group 共同创立,致力于开发调节先天免疫的纳米药物。Glass 先生在生命科学行业拥有逾 20 年的领导经验,曾担任 Vivasure Medical 首席执行官,此前还曾在 Abbott 担任高级管理职务逾 15 年。 继今年早些时候宣布董事会调整后,公司正从临床前阶段迈向临床阶段,Glass 先生于此时加入。他将运用在研发战略、融资及组织发展方面的专长,加快推进 TTxD 专有 RIDE 平台技术相关目标的实现,包括拓展免疫学与炎症领域的研发项目、确定 RIDE-002 的临床候选药物,以及持续维护利益相关方关系,为公司未来增长争取更多选择。 TTxD 董事长 Stefano Buono 表示: “我谨代表董事会,热烈欢迎 Andrew 在公司发展的关键时刻加入。他在创办创新...
-

Cleerly to Present Late-Breaking Results from the First Randomized Trial of AI-QCT-Guided Care in Patients with Stable Chest Pain at AHA 2026

DENVER--(BUSINESS WIRE)--Cleerly, a leader in AI-based cardiovascular imaging, announces its participation in the American Heart Association (AHA) Scientific Sessions 2026, November 6 to 9 at McCormick Place Convention Center in Chicago, Illinois. Cleerly will share primary results from PARAMOUNT, the first randomized trial to compare personalized care guided by AI-based quantitative coronary CT analysis (AI-QCT) with usual care in symptomatic patients with suspected coronary artery disease (CA...